{"article_title": "Amid Investor And Political Pressure, Walgreen Faces Domicile Decision", "article_keywords": ["amid", "decision", "political", "pressure", "faces", "walgreen", "investor", "domicile"], "article_url": "http://www.forbes.com/sites/brucejapsen/2014/06/24/amid-investor-and-political-pressure-walgreen-faces-domicile-decision/", "article_text": "", "article_metadata": {"description": "Walgreen Co. (WAG), closing in on key deadlines in its three-year plan to acquire European drugstore giant Alliance Boots, said an inversion remains on the table that would relocate the iconic brand from the U.S. to take advantage of a loophole that allows them to avoid higher corporate taxes here. Walgreen [...]", "author": "Bruce Japsen", "og": {"site_name": "Forbes", "description": "Walgreen Co. (WAG), closing in on key deadlines in its three-year plan to acquire European drugstore giant Alliance Boots, said an inversion remains on the table that would relocate the iconic brand from the U.S. to take advantage of a loophole that allows them to avoid higher corporate taxes here. Walgreen [...]", "title": "Amid Investor And Political Pressure, Walgreen Faces Domicile Decision", "url": "http://www.forbes.com/sites/brucejapsen/2014/06/24/amid-investor-and-political-pressure-walgreen-faces-domicile-decision/", "image": "http://blogs-images.forbes.com/brucejapsen/files/2014/06/6943291852_09896e1392_b.jpg", "updated_time": "2014-06-24T12:45:17-04:00", "type": "article"}, "twitter": {"description": "Walgreen Co. (WAG), closing in on key deadlines in its three-year plan to acquire European drugstore giant Alliance Boots, said an inversion remains on the table that would relocate the iconic brand from the U.S. to take advantage of a loophole that allows them to avoid higher corporate taxes here. Walgreen [...]", "creator": "@brucejapsen", "image": "http://blogs-images.forbes.com/brucejapsen/files/2014/06/6943291852_09896e1392_b.jpg", "title": "Amid Investor And Political Pressure, Walgreen Faces Domicile Decision", "site": "@forbes", "card": "summary_large_image"}, "apple-itunes-app": "app-id=588647136", "fb": {"app_id": 123694841080850}, "keywords": "Business,Health,Healthcare Innovation,Lifestyle,Pharma and Health,Retail,Wall Street,Washington,Pharma &amp; Healthcare,The Economy,Abbott Laboratories,Abbvie,Alliance Boots,Chicago,Dick Durbin,Merck,Pfizer,Tri-State Tollway,Walgreen", "article": {"publisher": "https://www.facebook.com/forbes", "section_url": "http://www.forbes.com/business", "section": "Business", "modified": "2014-06-24", "published": "2014-06-24", "id": "blogAndPostId/blog/post/2125-7074"}, "news_keywords": "Business,Health,Healthcare Innovation,Lifestyle,Pharma and Health,Retail,Wall Street,Washington,Pharma &amp; Healthcare,The Economy,Abbott Laboratories,Abbvie,Alliance Boots,Chicago,Dick Durbin,Merck,Pfizer,Tri-State Tollway,Walgreen", "viewport": "width=device-width,initial-scale=1,maximum-scale=1,user-scalable=no", "prerender-status-code": "{{meta.code}}"}, "article_summary": ""}